Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11040057 Pharmaceutical compositions and methods for potentiating gene silencing

Patent 11040057 was granted and assigned to OliX Pharmaceuticals on June, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 12 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 12 Dec, 2023
Edits made to:
Article (+349 characters)
Article

Patent abstract

In various aspects and embodiments, the invention provides compounds or agents that potentiate siRNA cellular entry or activity, and provides methods for identifying such compounds or agents. Exemplary agents that act as L-type calcium channel blockers are described herein, and are shown to potentiate gene silencing with cp-asiRNAs.

Edits on 25 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 25 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1104005700
Edits on 28 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Apr, 2023
Edits on 6 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 6 Apr, 2023
Edits on 2 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
OliX Pharmaceuticals
OliX Pharmaceuticals
0
Current Assignee
OliX Pharmaceuticals
OliX Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
110400570
Date of Patent
June 22, 2021
0
Patent Application Number
163137540
Date Filed
June 29, 2017
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=110400570
Patent Citations
‌
US Patent 10059949 Treatment of age-related macular degeneration using RNA complexes that target MYD88 or TLR3
0
‌
US Patent 10064801 RNA complexes that inhibit melanin production
0
‌
US Patent 10125362 RNA-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor
0
‌
US Patent 10214744 Nucleic acid molecules inducing RNA interference, and uses thereof
0
‌
US Patent 10238749 Angiotensinogen (AGT) iRNA compositions and methods of use thereof
0
‌
US Patent 10358648 Treatment of atopic dermatitis and asthma using RNA complexes that target IL4Rα, TRPA1, or F2RL1
0
‌
US Patent 10485885 Compositions and methods for delivery of agents
0
Patent Primary Examiner
‌
Sean McGarry
0
Edits on 30 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 30 Mar, 2023
Edits on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Mar, 2023
Edits on 27 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
OliX Pharmaceuticals
OliX Pharmaceuticals
0
Current Assignee
OliX Pharmaceuticals
OliX Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
110400570
Date of Patent
June 22, 2021
0
Patent Application Number
163137540
Date Filed
June 29, 2017
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=110400570
Patent Citations
‌
US Patent 10059949 Treatment of age-related macular degeneration using RNA complexes that target MYD88 or TLR3
0
‌
US Patent 10064801 RNA complexes that inhibit melanin production
0
‌
US Patent 10125362 RNA-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor
0
‌
US Patent 10214744 Nucleic acid molecules inducing RNA interference, and uses thereof
0
‌
US Patent 10238749 Angiotensinogen (AGT) iRNA compositions and methods of use thereof
0
‌
US Patent 10358648 Treatment of atopic dermatitis and asthma using RNA complexes that target IL4Rα, TRPA1, or F2RL1
0
‌
US Patent 10485885 Compositions and methods for delivery of agents
0
Patent Primary Examiner
‌
Sean McGarry
0
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 6 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 6 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=11040057
Edits on 12 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 12 Feb, 2022
Edits made to:
Infobox (+16 properties)
‌

 US Patent 11040057 Pharmaceutical compositions and methods for potentiating gene silencing

Infobox
Is a
Patent
Patent
Patent applicant
OliX Pharmaceuticals
OliX Pharmaceuticals
Current assignee
OliX Pharmaceuticals
OliX Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
11040057
Date of patent
June 22, 2021
Patent application number
16313754
Date Filed
June 29, 2017
Patent citations
‌
US Patent 10059949 Treatment of age-related macular degeneration using RNA complexes that target MYD88 or TLR3
‌
US Patent 10064801 RNA complexes that inhibit melanin production
‌
US Patent 10125362 RNA-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor
‌
US Patent 10214744 Nucleic acid molecules inducing RNA interference, and uses thereof
‌
US Patent 10238749 Angiotensinogen (AGT) iRNA compositions and methods of use thereof
‌
US Patent 10358648 Treatment of atopic dermatitis and asthma using RNA complexes that target IL4Rα, TRPA1, or F2RL1
‌
US Patent 10485885 Compositions and methods for delivery of agents
Patent primary examiner
‌
Sean McGarry

Find more entities like US Patent 11040057 Pharmaceutical compositions and methods for potentiating gene silencing

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo